Table 4.

The two-way ANOVA for the MELD score, the follow-up period, and the MELD score × the follow-up period interaction.

Lymphocyte subsets	Percentages			Absolute counts
	MELD score	Follow-up period	MELD score x follow-up period	MELD score	Follow-up period	MELD score x follow-up period
T	0.020	0.001	0.057	0.017	0.000	0.916
TCD4	0.019	0.003	0.305	0.042	0.001	0.849
TCD8	0.224	0.028	0.063	0.014	0.000	0.982
B	0.112	0.103	0.496	0.049	0.040	0.997
NK	0.770	0.309	0.481	0.174	0.006	0.694

MELD, model for end-stage liver disease; T, CD3⁺ T cells; TCD4, CD3⁺ CD4⁺ T cells; TCD8, CD3⁺ CD8⁺ T cells; B, CD19⁺ B cells; NK, CD56⁺ CD16⁺ natural killer cells.